KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,780,685 | -43.6% | 16,445 | -27.6% | 0.17% | -37.1% |
| Q2 2023 | $4,927,483 | -56.9% | 22,723 | -63.9% | 0.27% | -60.5% |
| Q1 2023 | $11,443,320 | -26.7% | 63,000 | -20.7% | 0.68% | -30.1% |
| Q4 2022 | $15,615,069 | -28.2% | 79,466 | -17.8% | 0.97% | -29.7% |
| Q3 2022 | $21,752,000 | +68.6% | 96,706 | -5.2% | 1.38% | +83.8% |
| Q2 2022 | $12,900,000 | -51.6% | 101,971 | -51.5% | 0.75% | -36.4% |
| Q1 2022 | $26,637,000 | -11.4% | 210,084 | -8.4% | 1.18% | +11.0% |
| Q4 2021 | $30,059,000 | +120.2% | 229,455 | +105.6% | 1.06% | +124.1% |
| Q3 2021 | $13,653,000 | -39.8% | 111,604 | -43.9% | 0.47% | -36.3% |
| Q2 2021 | $22,695,000 | +3.7% | 199,096 | +9.4% | 0.74% | +2.3% |
| Q1 2021 | $21,879,000 | – | 181,976 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |